Rchr
J-GLOBAL ID:201901002935050870
Update date: Jan. 02, 2025 Arai Takayuki
Arai Takayuki
Affiliation and department: Research field (2):
Urology
, Genomics
Research theme for competitive and other funds (6): - 2020 - 2023 網羅的マイクロRNA発現解析による去勢抵抗性前立腺癌・新規治療標的分子の探索
- 2018 - 2020 Identification of molecular mechanisms leading to treatment resistance in renal cell carcinoma based on functional RNA network analyses
- 2018 - 2019 機能性 RNA 解析に基づく、間質性膀胱炎・新規診断マーカーの探索
- 2018 - 2019 間質性膀胱炎・機能性RNAプロファイルの作成と新規分子ネットワークの探索
- 2018 - 2019 間質性膀胱炎・機能性RNAプロファイルの作成と新規分子ネットワークの探索
- 2016 - 2018 Elucidation of extracellular matrix molecular pathway regulated by metastasis-suppressing microRNAs in prostate cancer.
Show all
Papers (96): -
Yasutaka Yamada, Kodai Sato, Shinichi Sakamoto, Takuya Tsujino, Sinpei Saito, Kazuki Nishimura, Tatsuo Fukushima, Ko Nakamura, Yuki Yoshikawa, Tomohisa Matsunaga, et al. Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors. International journal of clinical oncology. 2024
-
Kodai Sato, Tomokazu Sazuka, Takayuki Arai, Hiroaki Sato, Manato Kanesaka, Keisuke Ando, Shinpei Saito, Sangjon Pae, Yasutaka Yamada, Yusuke Imamura, et al. Machine learning analysis for detecting late recurrence and loss to follow-up after renal cell carcinoma surgery. BJUI compass. 2024. 5. 10. 950-956
-
Bunpei Isoda, Shuya Kandori, Tomokazu Sazuka, Takahiro Kojima, Satoshi Nitta, Masanobu Shiga, Yoshiyuki Nagumo, Ayumi Fujimoto, Takayuki Arai, Hiroaki Sato, et al. TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab. International journal of molecular sciences. 2024. 25. 13
-
Hiroshi Masuda, Yuuki Amemiya, Natsuki Yagisawa, Takayuki Arai, Mitsuru Yanagisawa. Association Between Acute Kidney Injury and the Trendelenburg Position Angle During Robot-assisted Radical Prostatectomy. Anticancer research. 2024. 44. 4. 1767-1772
-
Junryo Rii, Shinichi Sakamoto, Atsushi Mizokami, Minhui Xu, Ayumi Fujimoto, Shinpei Saito, Hidekazu Koike, Takaaki Tamura, Takayuki Arai, Yasutaka Yamada, et al. L-type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel-resistant prostate cancer by inhibiting cyclin-dependent kinase activity. Cancer science. 2024
more... MISC (76): -
小林和樹, 坂本信一, 武井亮憲, 新納潤, 柴田裕貴, 塚本亮, 金坂学斗, 佐藤広明, 新井隆之, 竹内信善, et al. 前立腺癌に対するホルモン療法終了後のテストステロンリカバリーの検討. 日本性機能学会東部総会プログラム・抄録集. 2023. 32nd
-
佐藤広明, 塚本亮, 金坂学斗, 新井隆之, 竹内信善, 五島悠介, 佐塚智和, 今村有佑, 坂本信一, 市川智彦. Zero ischemia robot-assisted partial nephrectomy for hilar tumors. 日本泌尿器科学会総会(Web). 2023. 110th
-
三神功亮, 坂本信一, 柴田裕貴, 塚本亮, 金坂学斗, 佐藤広明, 新井隆之, 竹内信善, 五島悠介, 佐塚智和, et al. A case of incidental prostate cancer with multiple liver, lung, and bone metastases after HoLEP. 日本泌尿器科学会総会(Web). 2023. 110th
-
佐塚智和, 佐藤広明, 塚本亮, 新井隆之, 五島悠介, 今村有佑, 坂本信一, 市川智彦. 転移性腎癌一次治療におけるG8scoreの有用性の検討. 腎癌研究会会報. 2023. 53
-
佐藤広明, 塚本亮, 安藤敬佑, 金坂学斗, 新井隆之, 新井隆之, 五島悠介, 佐塚智和, 今村有佑, 坂本信一, et al. 腎門部腫瘍に対する無阻血RAPNの臨床的検討. 日本泌尿器内視鏡・ロボティクス学会(Web). 2023. 37th
more... Education (2): - 2015 - 2019 千葉大学大学院 医学研究院
- 2004 - 2010 Chiba University School of Medicine
Professional career (1): Work history (6): Awards (7): Return to Previous Page